BPC 157 was sold like a shortcut to recovery. But experimental does not mean safe, and viral does not mean proven. Maybe the real problem was never the warning it was the hype. # REDEFINE 1 trial: CagriSema demonstrates superior weight loss in adults with obesity or overweight Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Cagrilintide (AM833) Long acting amylin analog. Beta cells make TWO hormones: insulin and amylin. Amylin slows stomach emptying and reduces appetite. Cagrilintide is a long acting synthetic amylin designed for once weekly dosing